Status:

COMPLETED

Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus

Lead Sponsor:

Getz Pharma

Conditions:

Type 2 Diabetes

Eligibility:

All Genders

30-65 years

Phase:

PHASE4

Brief Summary

The aim of this study is to perform a comparison of the efficacy and safety of empagliflozin and vildagliptin in patients with Type 2 Diabetes Mellitus open labelled, multi-centric, parallel, randomi...

Detailed Description

Background: Diabetes is a rampant disease that keeps on getting more and more people affected each year. Over 200 million people have been affected worldwide due to this disorder, and many have contr...

Eligibility Criteria

Inclusion

  • Female and Male Patients of age 30-65 years with confirmed diagnosis of "type 2 diabetes mellitus".
  • Uncontrolled type 2 diabetes mellitus (\> 7% HbA1c patients on monotherapy of metformin for the past three months on a fixed dose of 1500 mg /day along with lifestyle modifications were included in this study.
  • BMI ranges from 18-45 kg/m2 were considered fit for this study. eGFR ≥ 60 ml/min/1.73 m2

Exclusion

  • Pregnant female or female patients planning to conceive during the study period were excluded from this study.
  • "Type 1 diabetes" or "secondary diabetes" resulting from specific causes Patients with advanced diabetic complications. Patients with any other terminal disease(s) requiring long-term medications. Patients involved in other trials on therapy with SGLT-2i or DPP4-I 3 months before study enrollment Patients on insulin or any other oral hypoglycemic drugs except metformin. Serum creatinine levels ≥ 1.3 mg/dl in women and ≥ 1.4 mg/dl in men

Key Trial Info

Start Date :

July 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 18 2021

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT05359432

Start Date

July 1 2020

End Date

August 18 2021

Last Update

May 3 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Diabetes and Endocrinology at Sindh Government Hospital New Karachi & Dr. Riasat Medical Center Allah Wala Town, Karachi, Pakistan

Karachi, Sindh, Pakistan, 75330